Crucial role of the 5-HT(2C) receptor, but not of the 5-HT(2A) receptor, in the down regulation of stimulated dopamine release produced by pressure exposure in freely moving rats

Brain Research

Volumn 796, Issue 1-2, 1998, Pages 143-149

  Kriem, Badreddine ^a   Rostain, Jean Claude ^b   Abraini, Jacques H ^a  

^a UNIVERSITÉ DE LORRAINE   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

Author keywords

5 HT2 receptor; Accumbens; Dopamine; High pressure neurological syndrome; Serotonin; Voltammetry

Indexed keywords

DOPAMINE; HELIUM; KETANSERIN; SEROTONIN; SEROTONIN 2A RECEPTOR; SEROTONIN 2C AGONIST; SEROTONIN 2C RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; ATMOSPHERIC PRESSURE; CONTROLLED STUDY; DOPAMINE RELEASE; HIGH PRESSURE NEUROLOGICAL SYNDROME; MALE; MOBILIZATION; NERVE EXCITABILITY; NONHUMAN; NUCLEUS ACCUMBENS; POTENTIOMETRY; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; RECEPTOR BLOCKING; SEROTONIN RELEASE;

EID: 0032526824     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)00338-2     Document Type: Article

References (38)

1. Abraini J.H., Fechtali T. A hypothesis regarding possible interactions between the pressure-induced disorders in dopaminergic and amino-acidergic transmission. Neurosci. Biobehav. Rev. 16:1992;597-602.
2. Abraini J.H., Rostain J.-C. Pressure-induced striatal dopamine release correlates hyperlocomotor activity in rats exposed to high pressure. J. Appl. Physiol. 71:1991;638-643.
3. Abraini J.H., Rostain J.-C. Dopamine increase in the nucleus accumbens of rats exposed to high pressure. Neuroreport. 2:1991;233-235.
4. Abraini J.H., Rostain J.-C. Effects of the administration of α-methyl-p-tyrosine on the striatal dopamine increase and the behavioral motor disturbances in rats exposed to high pressure. Pharmacol. Biochem. Behav. 40:1991;305-310.
5. Abraini J.H., Tomei C., Rostain J.-C. Role of dopamine receptors in the occurrence of the behavioral motor disturbances in rats exposed to high pressure. Pharmacol. Biochem. Behav. 39:1991;773-779.
6. 2 receptors. Neuroscience. 50:1992;395-402.
7. Abraini J.H., Ansseau M., Fechtali T. Pressure-induced disorders in neurotransmission and spontaneous behavior in rats: an animal model of psychosis. Biol. Psychiatry. 34:1993;622-629.
8. Abraini J.H., Fechtali T., Rostain J.-C. Lasting effects of dopamine receptor agonists upon striatal dopamine release in free-moving rats: an in vivo voltammetric study. Brain Res. 642:1994;199-205.
9. Benloucif S., Galloway M.P. Facilitation of dopamine release in vivo by serotonin agonists: studies with microdialysis. Eur. J. Pharmacol. 200:1991;1-8.
10. Bradley P.B., Engel G., Feniuk W., Fozard J.R., Humphrey P.P.A., Middlemiss D.N., Mylecharane E.J., Richardson B.P., Saxena P.R. Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine. Neuropharmacology. 25:1986;563-576.
11. 1C receptors. Trends Pharmacol. Sci. 11:1990;181-182.
12. Darbin O., Risso J.-J., Rostain J.-C. High pressure-induced striatal serotonin release: an in vivo microdialysis study in free-moving rats. Undersea Hyperbaric Med. 24:1997;64. Suppl.
13. El Ganouni S., Forni C., Nieoullon A. In vitro and in vivo characterization of the properties of a multifiber carbon electrode allowing long-term electrochemical detection of dopamine in freely moving animals. Brain Res. 404:1987;239-256.
14. Fechtali T., Abraini J.H., Kriem B., Rostain J.-C. Pressure increases de novo synthesized striatal dopamine release in free-moving rats. Neuroreport. 5:1994;725-728.
15. Forni C. Realization of a new multifiber electrochemical device allowing continuous in vivo measurements of neuromediators. J. Neurosci. Methods. 5:1982;167-171.
16. Forni C., Nieoullon A. Electrochemical detection of dopamine release in the striatum of freely moving rats. Brain Res. 297:1984;11-20.
17. Halsey M.J. Effect of high pressure on the central nervous system. Physiol. Rev. 62:1982;1341-1377.
18. Hoyer D., Clarke D.E., Fozard J.R., Hartig P.R., Martin G.R., Mylecharane E.J., Saxena P.R., Humphrey P.P.A. VII. International union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol. Rev. 46:1994;157-203.
19. Kissinger P.T., Hart J.B., Adams R.N. Voltammetry in brain tissue - a new neurophysiological measurement. Brain Res. 55:1973;209-213.
20. J.F.R., König, R.A. Klippel, The Rat Brain: A Stereotaxic Atlas, Kriegger, New York, 1967.
21. 3 receptor in the pressure-induced increase in striatal and accumbens dopamine release and the occurrence of behavioral disorders in free-moving rats. Neurosci. Lett. 197:1995;57-60.
22. 1b receptors in the pressure-induced behavioral and neurochemical disorders in rats. Pharmacol. Biochem. Behav. 53:1996;257-264.
23. 2 receptors in the occurrence of locomotor activity and myoclonia in freely moving rats exposed to high pressure. Neuroreport. 7:1996;2687-2690.
24. 1 receptors and behavior. Neurosci. Biobehav. Rev. 16:1992;83-93.
25. Lucki I., Ward H.R., Frazer A. Effect of 1-(m-chlorophenyl)piperazine and 1-(m-trifluoromethylphenyl) piperazine on locomotor activity. J. Pharmacol. Exp. Ther. 249:1989;155-164.
26. Nash J.F. Ketanserin pretreatment attenuates MDMA-induced dopamine release in the striatum as measured by in vivo microdialysis. Life Sci. 47:1990;2401-2408.
27. Nash J.F., Brodkin J. Microdialysis studies on 3,4-methylenedioxymethamphetamine-induced dopamine release: effect of dopamine uptake inhibitors. J. Pharmacol. Exp. Ther. 259:1991;820-825.
28. Nash J.F., Meltzer H.Y., Gudelsky G.A. Effect of 3,4-methylenedioxy-methamphetamine on 3,4-dihydroxyphenylalanine accumulation in the striatum and the nucleus accumbens. J. Neurochem. 54:1990;1062-1067.
29. Pessia M., Jiang Z.-G., North R.A., Johnson S.W. Action of 5-hydroxytryptamine on ventral tegmental area neurons of the rat in vitro. Brain Res. 654:1994;324-330.
30. Prisco S., Pagannone S., Esposito E. Serotonin-dopamine interaction in the rat ventral tegmental area: an electrochemical study in vivo. J. Pharmacol. Exp. Ther. 271:1994;83-90.
31. J.-C., Rostain, The nervous system: man and laboratory mammals, in: A.G. Macdonald (Ed.), Advances in Comparative and Environmental Physiology: Effects of High Pressure on Biological Systems, Vol. 17, Springer-Verlag, Berlin, 1993, pp. 197-238.
32. Rostain J.-C., Wardley-Smith B., Forni C., Halsey M.J. Gamma aminobutyric acid and the high pressure neurological syndrome. Neuropharmacology. 25:1986;545-554.
33. Requin M., Risso J.-J. Effects of high pressure on dopamine release in freely moving rats: a microdialysis study. Neurosci. Lett. 146:1992;211-214.
34. 2 receptors exert a state dependent regulation of dopaminergic function. Studies with MDL 100,907 and the amphetamine analogue 3,4-methylenedioxymethamphetamine. Eur. J. Pharmacol. 223:1992;65-74.
35. 2 receptors reduces the increase in extracellular concentrations of dopamine produced by the amphetamine analogue 3,4-methylenedioxymeth-amphetamine. J. Neurochem. 62:1994;1382-1389.
36. Sharma A., Punhani T., Fone K.C. Distribution of the 5-hydroxytryptamine 2C receptor protein in adult rat brain and spinal cord determine using receptor-directed antibody: effect of 5,7-dihydroxytryptamine. Synapse. 27:1997;45-56.
37. 2 antagonists reverse amphetamine-induced slowing of dopaminergic neurons by interfering with stimulated dopamine synthesis. J. Pharmacol. Exp. Ther. 260:1992;872-878.
38. Zifa E., Fillion G. 5-hydroxytryptamine receptors. Pharmacol. Rev. 44:1992;401-458.